Featured Articles

  1. Patient-Centric Trials: Overcome Enrollment Challenges By Putting Patients First 6/11/2019

    Just as patients have a stronger voice in today’s healthcare marketplace, that voice should resonate earlier in the drug development process. By adopting a patient-centric approach during protocol design and in day-to-day study management, sponsors can expect improved patient enrollment and retention, as well as a cleaner study with definitive outcomes.

  2. Making The Most Of Clinical Trial Data 5/22/2019

    To control costs, improve efficiency, and successfully bring more drugs to market—life-changing, life-saving drugs—pharma and biopharma companies need to follow the lead of the financial industry and forward-thinking health systems. Here, we discuss how a data-driven approach to clinical trials—from patient recruitment to post-regulatory approval—can put an end to missed deadlines, failed studies, and wasted time and money.

  3. Advanced Analytics For The Monitoring Of Clinical Trials 4/26/2019

    Clinical research generates a massive amount of data. Unfortunately, because of the way most clinical data programs currently work, much of these data are not used to their fullest extent; they are simply filed away. This white paper will focus on the benefits provided by a unique and advanced analytical approach to study monitoring beyond the minimum necessary RBM approach.

  4. Rescue Is Not A Dirty Word: 3 Measures To Overcome Operational Failures 4/26/2019

    - Every year, tens of thousands of clinical trials are initiated. Every year, thousands of those trials falter, and, if corrective action isn’t taken, some may fail to produce usable data. In this white paper, we want to attempt to characterize the scope of the problem facing the drug development industry, and make a case for early, proactive intervention in faltering clinical trials.

  5. How Virtual Trials Support Patient-Centricity 4/24/2019

    In this digital age, virtual trials may very well become the norm at some point in the future, but there are many questions to answer before this can become a reality. In this white paper, we propose how virtual trials may be able to solve all these issues at once while also providing the added benefit of reducing costs related to study sites.

  6. A Patient-Centric Approach Rescues Complex TBI Study 4/24/2019

    Site selection and ensuring that sites are performing up to par are crucial parts of a study. Read how a CRO facilitated communication between participants and sites and personally took measures to follow up with participants who would have been otherwise lost between screening visits.

  7. Strict Processes Rescue Complex MS Trial 4/23/2019

    A specialty pharmaceutical company engaged Biorasi to rescue their phase 2 clinical trial for treatment of spasticity caused by multiple sclerosis (MS) after an incumbent CRO was not meeting enrollment expectations. Read how Biorasi’s project management-first approach allowed rapid feasibility and site startup to meet critical deadlines.

  8. An Innovative Approach To Solve An RLD Shortage 4/23/2019

    Limited or no availability of the Reference Listed Drug (RLD) for a generic dermatology trial can seriously hinder the feasibility of a study. An innovative approach including the enrollment of patients with very high potential of protocol adherence and effective patient engagement to minimize the rate of retreatment throughout the study resulted in a successful study.

  9. Dermatology Expertise Helps Biorasi Recruit In Challenging Conditions 4/23/2019

    Patient compliance was a serious concern, particularly regarding the reduction of sun exposure. Running a dermatology trial, especially in the middle of summer, can greatly affect patient compliance and the resulting, potential flare-ups in any dermatological condition. Read how implementing various layers of risk mitigation can assist in offsetting any foreseen compliance issues.

  10. A Modern Approach To Patient Education Increases Enrollment 4/23/2019

    Running a trial for dermatology injectables when topical alternatives exist presents unique challenges. Read how an interactive solution increased enrollment and compliance with injectables.